NovaVision
Latest round
- Series C
Last raised
- Dec 2006
Total raised
- $38M
Investors
- 6
About NovaVision
NovaVision, Inc.Founded in 1998 in Boca Raton, US, NovaVision, Inc. specializes in vision restoration therapy.90 mn from Vycor Medical, Inc.NovaVision specializes in vision restoration therapy targeted at stroke and traumatic brain injury (TBI) patients, offering two primary product lines: Vision Restoration Therapy (VRT) and NeuroEyeCoach. VRT is an FDA-cleared treatment designed to stimulate impaired visual functions through repetitive light stimulation, aiming to improve the sensitivity of a patient's field of vision and enhance residual vision in areas of partial injury. NeuroEyeCoach complements this by training patients to effectively scan their surroundings and utilize remaining visual fields, integrating left and right vision. These products are designed for both individual patients and medical professionals, serving a broad client base that includes stroke survivors and rehabilitation facilities across the United States, with a focus on addressing the substantial gap in post-stroke vision rehabilitation therapies.NovaVision's revenue model revolves around the provision of therapeutic services via its flagship offerings, VRT and NeuroEyeCoach. The company operates on a direct-to-consumer basis, allowing patients to access these therapies through subscriptions or one-time purchases via an online platform. Payment structures may include monthly subscriptions for at-home therapy programs or fees for individual therapy sessions, tailored to meet the needs of stroke and TBI patients. The integration of both VRT and NeuroEyeCoach into a comprehensive therapy suite provides a unique value proposition in the market, catering to both patient needs and physician referrals., with the investment expected to strengthen the company's capabilities while supporting its next phase of growth. The company is focusing on launching new products designed to enhance vision restoration therapies and plans to expand its services into additional markets, particularly targeting regions with high incidences of stroke and TBI. Specific timelines for these initiatives have not been disclosed.
Who invested in NovaVision
6 investors across 3 rounds
See all investors in NovaVision
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NovaVision
Who invested in NovaVision?
NovaVision has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NovaVision raised?
NovaVision has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NovaVision last raise money?
NovaVision's most recent round on record is a Series C, in Dec 2006.
What does NovaVision do?
NovaVision is a medical devices & equipment company.
Where is NovaVision headquartered?
NovaVision is headquartered in Boca Raton, US.
Which VCs invest in companies like NovaVision?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at NovaVision's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like NovaVision? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.